ロード中...
Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer
BACKGROUND: Methionyl-tRNA synthetase (MRS) plays a critical role in initiating translation by transferring Met to the initiator tRNA (tRNA(i) (Met)) and protection against ROS-mediated damage, suggesting that its overexpression is related to cancer growth and drug resistance. In this study, the cli...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497355/ https://ncbi.nlm.nih.gov/pubmed/28679377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3452-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|